Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Brought to you by

First financing for Amsterdam Molecular grosses €22mm

Executive Summary

Amsterdam Molecular Therapeutics BV (medicinal genes for metabolic, neurological, and ophthalmic diseases) raised €22mm ($28mm) in a Series A financing that was led by ABN AMRO Capital/Life Sciences and included Advent Venture Partners, Gilde Healthcare Partners, and Credit Agricole Private Equity.
Deal Industry
  • Pharmaceuticals
  • Pharmaceuticals
    • Drug Delivery
      • Macromolecule
  • Biotechnology
    • Gene Therapy, Cell Therapy
    • Large Molecule
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies

UsernamePublicRestriction

Register